Mast cell degranulation contributes to susceptibility to Leishmania major

Parasite Immunology

Volumn 31, Issue 3, 2009, Pages 140-146

  RomAo P R T ^b   Da Costa Santiago, H ^a   Ramos, C D L ^c   De Oliveira, C F E ^a   Monteiro, M C ^d   De Queiroz Cunha, F ^e   Vieira, L Q ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b UNIVERSIDADE DO EXTREMO SUL CATARINENSE   (Brazil)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

^d UNIVERSIDADE ESTADUAL DO CENTRO OESTE   (Brazil)

^e UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

IL 4; IL 4 knockout; Leishmania major; Leishmaniasis; Mast cell

Indexed keywords

COMPOUND 48-80; GAMMA INTERFERON; INTERLEUKIN 4; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE; RANTES;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BAGG ALBINO MOUSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; FEMALE; IN VIVO STUDY; INFECTION SENSITIVITY; LEISHMANIA MAJOR; MAST CELL; MAST CELL DEGRANULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CELL DEGRANULATION; CHEMOKINE CCL2; CHEMOKINE CCL5; DISEASE SUSCEPTIBILITY; FEMALE; FOOT; GENE EXPRESSION PROFILING; INTERFERON-GAMMA; INTERLEUKIN-4; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; MAST CELLS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; NITRIC OXIDE;

ANIMALIA; LEISHMANIA MAJOR; MUS;

EID: 60349107085     PISSN: 01419838     EISSN: 13653024     Source Type: Journal    
DOI: 10.1111/j.1365-3024.2008.01084.x     Document Type: Article

References (28)

1. Scott P. IFN-γ modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis. J Immunol 1991 147 : 3149 3155.
2. Liew FY, Li Y Millott S. Tumor necrosis factor-alpha synergizes with IFN-γ in mediating killing of Leishmania major through the induction of nitric oxide. J Immunol 1990 145 : 4306 4310.
3. Lima GM, Vallochi AL, Silva UR, Bevilacqua EM, Kiffer MM Abrahamsohn IA. The role of polymorphonuclear leukocytes in the resistance to cutaneous Leishmaniasis. Immunol Lett 1998 64 : 145 151.
4. Fonseca SG, Romao PR, Figueiredo F, et al. TNF-α mediates the induction of nitric oxide synthase in macrophages but not in neutrophils in experimental cutaneous leishmaniasis. European J Immunol 2003 33 : 2297 2306.
5. Oliveira SH, Fonseca SG, Romao PR, Figueiredo F, Ferreira SH Cunha FQ. Microbicidal activity of eosinophils is associated with activation of the arginine-NO pathway. Parasite Immunol 1998 20 : 405 412.
6. Silveira FT, Lainson R Corbett CE. Further observations on clinical, histopathological, and immunological features of borderline disseminated cutaneous leishmaniasis caused by Leishmania (Leishmania) amazonensis. Mem Inst Oswaldo Cruz 2005 100 : 525 534.
7. Da-Cruz AM, Bertho AL, Oliveira-Neto MP Coutinho SG. Flow cytometric analysis of cellular infiltrate from American tegumentary leishmaniasis lesions. Br J Dermatol 2005 153 : 537 543.
8. Wershil BK, Theodos CM, Galli SJ Titus RG. Mast cells augment lesion size and persistence during experimental Leishmania major infection in the mouse. J Immunol 1994 152 : 4563 4571.
9. Bradding P Holgate ST. Immunopathology and human mast cell cytokines. Crit Rev Oncol Hematol 1999 31 : 119 133.
10. Maurer M, Lopez KS, Siebenhaar F, et al. Skin mast cells control T cell-dependent host defense in Leishmania major infections. FASEB J 2006 20 : 2460 2467.
11. de Oliveira MP, Lima MC, Calheiros AS, et al. Leishmania (Viannia) braziliensis: human mast cell line activation induced by logarithmic and stationary promastigote derived-lysates. Exp Parasitol 2005 109 : 72 79.
12. Pos Z, Muller K, Novalphak I, et al. Different patterns of the 1-histidine decarboxylase (HDC) gene expression in mice resistant and susceptible to experimental cutaneous leishmaniasis. Inflamm Res 2004 53 : 38 43.
13. Saha B, Tonkal AM, Croft S Roy S. Mast cells at the host-pathogen interface: host-protection versus immune evasion in leishmaniasis. Clin Exp Immunol 2004 July 137 : 19 23.
14. Burd PR, Thompson WC, Max EE Mills FC. Activated mast cells produce interleukin 13. J Exp Med 1995 181 : 1373 1380.
15. Mohrs M, Ledermann B, Kohler G, Dorfmuller A, Gessner A Brombacher F. Differences between IL-4- and IL-4 receptor α-deficient mice in chronic leishmaniasis reveal a protective role for IL-13 receptor signaling. J Immunol 1999 162 : 7302 7308.
16. Galli SJ, Gordon JR Wershil BK. Cytokine production by mast cells and basophils. Curr Opin Immunol 1991 3 : 865 872.
17. Noben-Trauth N, Kohler G, Burki K Ledermann B. Efficient targeting of the IL-4 gene in a BALB/c embryonic stem cell line. Transgenic Res 1996 5 : 487 491.
18. Ramos CD, Heluy-Neto NE, Ribeiro RA, Ferreira SH Cunha FQ. Neutrophil migration induced by IL-8-activated mast cells is mediated by CINC-1. Cytokine 2003 21 : 214 223.
19. Katakura K, Saito S, Hamada A, Matsuda H Watanabe N. Cutaneous leishmaniasis in mast cell-deficient W/Wv mice. Infect Immun 1993 61 : 2242 2244.
20. Elenkov IJ, Webster E, Papanicolaou DA, Fleisher TA, Chrousos GP Wilder RL. Histamine potently suppresses human IL-12 and stimulates IL-10 production via H2 receptors. J Immunol 1998 161 : 2586 2593.
21. Horvath BV, Szalai C, Mandi Y, et al. Histamine and histamine-receptor antagonists modify gene expression and biosynthesis of interferon gamma in peripheral human blood mononuclear cells and in CD19-depleted cell subsets. Immunol Let 1999 70 : 95 99.
22. Zaph C Scott P. Interleukin-12 regulates chemokine gene expression during the early immune response to Leishmania major. Infect Immun 2003 71 : 1587 1589.
23. Ritter U, Moll H, Laskay T, et al. Differential expression of chemokines in patients with localized and diffuse cutaneous American leishmaniasis. J Infect Dis 1996 173 : 699 709.
24. Santiago HC, Oliveira CF, Santiago L, et al. Involvement of the chemokine RANTES (CCL5) in resistance to experimental infection with Leishmania major. Infect Immun 2004 72 : 4918 4923.
25. Li Y, Nguyen TD, Stechschulte AC, Stechschulte DJ Dileepan KN. Effect of mast cell granules on the gene expression of nitric oxide synthase and tumour necrosis factor-α in macrophages. Med Inflamm 1998 7 : 355 361.
26. Mahmoodi M, Rajabalian S, Fekri A Esfandiarpour I. Evaluation of in vitro production of IFN-γ, IL-10, IL-12 and IL-13 by blood cells in patients with cutaneous leishmaniasis lesions. Iran J Allergy Asthma Immunol 2005 4 : 15 21.
27. +Foxp3-negative T cells as a source of IL-10 in Leishmania major susceptibility. J Immunol 2007 179 : 2435 2444.
28. Kane MM Mosser DM. The role of IL-10 in promoting disease progression in leishmaniasis. J Immunol 2001 166 : 1141 1147.